Differentiated development program includes two Nkarta clinical trials and two investigator-sponsored trials of NKX019 in rheumatic and ...

Company provides financial targets for fiscal 2026 of mid-single digit organic revenue growth and modest adjusted operating margin expansion GRAND RAPIDS, Mich., March 26, 2025 (GLOBE NEWSWIRE) -- ...